Role of PEG35, Mitochondrial ALDH2, and Glutathione in Cold Fatty Liver Graft Preservation: An IGL-2 Approach
暂无分享,去创建一个
J. Roselló-Catafau | E. Folch-Puy | C. Palmeira | J. Pirenne | T. Carbonell | Raquel G Bardallo | Rui T Da Silva | R. Adam | A. Panisello-Roselló | Arnau Panisello-Roselló
[1] M. Boros,et al. Mitochondrial Consequences of Organ Preservation Techniques during Liver Transplantation , 2021, International journal of molecular sciences.
[2] S. Fieuws,et al. The effect of organ preservation solutions on short‐term outcomes after liver transplantation: a single‐center retrospective study , 2020, Transplant international : official journal of the European Society for Organ Transplantation.
[3] J. Roselló-Catafau,et al. HOPE (hypothermic oxygenated perfusion) strategies in the era of dynamic liver graft preservation , 2020, EBioMedicine.
[4] D. Meierhofer,et al. Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation , 2020, EBioMedicine.
[5] E. Folch-Puy,et al. Polyethylene Glycol 35 as a Perfusate Additive for Mitochondrial and Glycocalyx Protection in HOPE Liver Preservation , 2020, International journal of molecular sciences.
[6] S. Donnini,et al. Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing , 2020, Biomedicines.
[7] A. Somov,et al. Organ Preservation into the 2020s: The Era of Dynamic Intervention , 2019, Transfusion Medicine and Hemotherapy.
[8] Hailong Wu,et al. Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice , 2018, Journal of immunology research.
[9] V. Giorgio,et al. ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties , 2018, Oxidative medicine and cellular longevity.
[10] J. Roselló-Catafau,et al. Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury , 2018, International journal of molecular sciences.
[11] J. Roselló-Catafau,et al. Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update , 2018, World journal of gastroenterology.
[12] Wen‐qi Huang,et al. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress , 2018, Free radical research.
[13] J. Roselló-Catafau,et al. Cytoprotective Mechanisms in Fatty Liver Preservation against Cold Ischemia Injury: A Comparison between IGL-1 and HTK , 2018, International journal of molecular sciences.
[14] J. Decuypere,et al. The Crosstalk between ROS and Autophagy in the Field of Transplantation Medicine , 2017, Oxidative medicine and cellular longevity.
[15] Kedar Ghimire,et al. Nitric oxide: what's new to NO? , 2017, American journal of physiology. Cell physiology.
[16] J. Roselló-Catafau,et al. Polyethylene glycols: An effective strategy for limiting liver ischemia reperfusion injury. , 2016, World journal of gastroenterology.
[17] P. Bachellier,et al. Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] J. Roselló-Catafau,et al. Polyethylene glycol rinse solution: an effective way to prevent ischemia-reperfusion injury. , 2014, World journal of gastroenterology.
[19] H. Ohdan,et al. Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery , 2014, Surgery Today.
[20] A. Said. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. , 2013, World journal of gastroenterology.
[21] S. Donnini,et al. Mitochondrial aldehyde dehydrogenase-2 activation prevents &bgr;-amyloid-induced endothelial cell dysfunction and restores angiogenesis , 2013, Journal of Cell Science.
[22] A. Seifalian,et al. The nitric oxide pathway – evidence and mechanisms for protection against liver ischaemia reperfusion injury , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[23] K. Vekemans,et al. Presumed and actual concentrations of reduced glutathione in preservation solutions. , 2011, Transplantation proceedings.
[24] J. Roselló-Catafau,et al. How to protect liver graft with nitric oxide. , 2011, World journal of gastroenterology.
[25] Alexander Y. Petrenko,et al. Organ Preservation: Current Concepts and New Strategies for the Next Decade , 2011, Transfusion Medicine and Hemotherapy.
[26] J. Roselló-Catafau,et al. Pharmacological strategies against cold ischemia reperfusion injury , 2010, Expert opinion on pharmacotherapy.
[27] D. Segev,et al. Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] Wentao Gao,et al. Autophagy in the liver , 2008, Hepatology.
[29] R. Franco-Gou,et al. Preservation of steatotic livers in IGL‐1 solution , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[30] G. Escolar,et al. Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity. , 2006, Transplantation proceedings.
[31] J. Roselló-Catafau,et al. The future of fatty livers. , 2004, Journal of hepatology.
[32] R. Busuttil,et al. The utility of marginal donors in liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[33] B. Descamps-Latscha,et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. , 2003, Kidney international.
[34] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[35] P. Clavien,et al. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. , 2017, Journal of hepatology.
[36] Julio C. B. Ferreira,et al. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. , 2014, Physiological reviews.
[37] F. Ramalho,et al. Hepatic microcirculatory failure. , 2006, Acta cirurgica brasileira.
[38] P A Clavien,et al. Fatty Liver in Liver Transplantation and Surgery , 2001, Seminars in liver disease.